Aytu BioPharma, Inc. (AYTU) Expected Move

Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.

Aytu BioPharma, Inc. (AYTU) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry, with a market capitalization near $18.5M, listed on NASDAQ, employing roughly 102 people, carrying a beta of 0.28 to the broader market. Aytu Biopharma, Inc. Led by Joshua R. Disbrow, public since 2008-09-25.

Expected move analysis estimates the probable price range implied by options pricing. No recent options activity for AYTU as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how expected move is reported and how to read the data →